These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10332072)
21. The preparation of felodipine/zein amorphous solid dispersions and in vitro evaluation using a dynamic gastrointestinal system. Zhang H; Liu X; Ma X Pharm Dev Technol; 2020 Dec; 25(10):1226-1237. PubMed ID: 32787680 [TBL] [Abstract][Full Text] [Related]
22. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. Patil H; Feng X; Ye X; Majumdar S; Repka MA AAPS J; 2015 Jan; 17(1):194-205. PubMed ID: 25344439 [TBL] [Abstract][Full Text] [Related]
23. Effect of para-sulfonato-calix[n]arenes on the solubility, chemical stability, and bioavailability of a water insoluble drug nifedipine. Yang W; Otto DP; Liebenberg W; de Villiers MM Curr Drug Discov Technol; 2008 Jun; 5(2):129-39. PubMed ID: 18673251 [TBL] [Abstract][Full Text] [Related]
24. Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process. Ahn JB; Kim DH; Lee SE; Pyo YC; Park JS Int J Pharm; 2019 Jun; 564():263-272. PubMed ID: 31015003 [TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838 [TBL] [Abstract][Full Text] [Related]
26. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process. Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066 [TBL] [Abstract][Full Text] [Related]
27. Design of fenofibrate microemulsion for improved bioavailability. Hu L; Wu H; Niu F; Yan C; Yang X; Jia Y Int J Pharm; 2011 Nov; 420(2):251-5. PubMed ID: 21907776 [TBL] [Abstract][Full Text] [Related]
28. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine. Lee KR; Kim EJ; Seo SW; Choi HK Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792 [TBL] [Abstract][Full Text] [Related]
29. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments. O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636 [TBL] [Abstract][Full Text] [Related]
30. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state. Weerapol Y; Limmatvapirat S; Jansakul C; Takeuchi H; Sriamornsak P Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879 [TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches. Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001 [TBL] [Abstract][Full Text] [Related]
32. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate. Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471 [TBL] [Abstract][Full Text] [Related]
33. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability. Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621 [TBL] [Abstract][Full Text] [Related]
34. Manufacturing nanosized fenofibrate by salt assisted milling. Mochalin VN; Sagar A; Gour S; Gogotsi Y Pharm Res; 2009 Jun; 26(6):1365-70. PubMed ID: 19224343 [TBL] [Abstract][Full Text] [Related]
35. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery. Li DX; Kim JO; Oh DH; Lee WS; Hong MJ; Kang JY; Choi JS; Woo JS; Yong CS; Choi HG Arch Pharm Res; 2009 Jan; 32(1):127-32. PubMed ID: 19183885 [TBL] [Abstract][Full Text] [Related]
36. Supercritical carbon dioxide solubility measurement and modelling for effective size reduction of nifedipine particles for transdermal application. Massias T; de Paiva Lacerda S; Resende de Azevedo J; Letourneau JJ; Bolzinger MA; Espitalier F Int J Pharm; 2023 Jan; 630():122425. PubMed ID: 36436744 [TBL] [Abstract][Full Text] [Related]
37. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms. Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657 [TBL] [Abstract][Full Text] [Related]
38. Micronization, characterization and in-vitro dissolution of shellac from PGSS supercritical CO2 technique. Labuschagne PW; Naicker B; Kalombo L Int J Pharm; 2016 Feb; 499(1-2):205-216. PubMed ID: 26707412 [TBL] [Abstract][Full Text] [Related]
39. Loading amorphous Asarone in mesoporous silica SBA-15 through supercritical carbon dioxide technology to enhance dissolution and bioavailability. Zhang Z; Quan G; Wu Q; Zhou C; Li F; Bai X; Li G; Pan X; Wu C Eur J Pharm Biopharm; 2015 May; 92():28-31. PubMed ID: 25720818 [TBL] [Abstract][Full Text] [Related]
40. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Khani S; Keyhanfar F; Amani A Drug Deliv; 2016 Jul; 23(6):2035-43. PubMed ID: 26406153 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]